John S Albin, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytosine Deaminase | 8 | 2015 | 65 | 1.950 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 9 | 2018 | 53 | 1.520 |
Why?
|
| HIV-1 | 10 | 2018 | 6848 | 0.630 |
Why?
|
| Gene Products, vif | 1 | 2013 | 32 | 0.460 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2022 | 1161 | 0.430 |
Why?
|
| Cytidine Deaminase | 6 | 2013 | 245 | 0.420 |
Why?
|
| Physicians | 2 | 2022 | 4586 | 0.290 |
Why?
|
| Bacteriocins | 1 | 2024 | 89 | 0.230 |
Why?
|
| Bedding and Linens | 1 | 2023 | 41 | 0.210 |
Why?
|
| HIV Infections | 4 | 2018 | 17128 | 0.210 |
Why?
|
| Oxidative Phosphorylation | 1 | 2024 | 495 | 0.200 |
Why?
|
| Anthozoa | 1 | 2021 | 65 | 0.190 |
Why?
|
| Science | 1 | 2021 | 240 | 0.160 |
Why?
|
| Latent Tuberculosis | 1 | 2021 | 224 | 0.150 |
Why?
|
| Virus Replication | 3 | 2018 | 2431 | 0.150 |
Why?
|
| Research Personnel | 1 | 2021 | 582 | 0.140 |
Why?
|
| Cell Line | 5 | 2015 | 15636 | 0.130 |
Why?
|
| Protein Binding | 3 | 2013 | 9334 | 0.120 |
Why?
|
| Amino Acid Substitution | 3 | 2018 | 1737 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 3 | 2018 | 1448 | 0.110 |
Why?
|
| Biocatalysis | 1 | 2013 | 173 | 0.110 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 1758 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2015 | 1694 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 1295 | 0.090 |
Why?
|
| Genes, vif | 1 | 2010 | 16 | 0.090 |
Why?
|
| T-Lymphocytes | 3 | 2013 | 10181 | 0.080 |
Why?
|
| Macaca mulatta | 2 | 2014 | 2315 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 3800 | 0.070 |
Why?
|
| Exoribonucleases | 1 | 2008 | 98 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 1230 | 0.070 |
Why?
|
| Capsid | 1 | 2010 | 434 | 0.070 |
Why?
|
| DNA Primers | 1 | 2010 | 2817 | 0.070 |
Why?
|
| Selection, Genetic | 1 | 2010 | 872 | 0.060 |
Why?
|
| Simian immunodeficiency virus | 1 | 2010 | 805 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2022 | 4737 | 0.060 |
Why?
|
| Escherichia coli K12 | 1 | 2024 | 34 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2008 | 563 | 0.060 |
Why?
|
| DNA, Viral | 1 | 2010 | 2195 | 0.050 |
Why?
|
| Monkeypox virus | 1 | 2023 | 42 | 0.050 |
Why?
|
| Biological Evolution | 1 | 2008 | 1072 | 0.050 |
Why?
|
| Mutation | 3 | 2018 | 29877 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2008 | 866 | 0.050 |
Why?
|
| Humans | 14 | 2023 | 759255 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 330 | 0.040 |
Why?
|
| Base Sequence | 1 | 2010 | 12450 | 0.040 |
Why?
|
| Alleles | 1 | 2010 | 6897 | 0.040 |
Why?
|
| RNA Interference | 1 | 2008 | 2847 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2008 | 1443 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2024 | 1994 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 547 | 0.040 |
Why?
|
| Specialization | 1 | 2021 | 779 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 2135 | 0.030 |
Why?
|
| Syndrome | 1 | 2023 | 3276 | 0.030 |
Why?
|
| Static Electricity | 1 | 2015 | 261 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2008 | 4939 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 2021 | 879 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 434 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 492 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2024 | 4222 | 0.020 |
Why?
|
| Catalysis | 1 | 2013 | 775 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 616 | 0.020 |
Why?
|
| Massachusetts | 1 | 2023 | 8788 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2018 | 2837 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2021 | 9711 | 0.020 |
Why?
|
| Animals | 4 | 2021 | 167838 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 17750 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 1978 | 0.020 |
Why?
|
| Homeostasis | 1 | 2018 | 3304 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 6053 | 0.020 |
Why?
|
| Multigene Family | 1 | 2010 | 1079 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 752 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2008 | 294 | 0.020 |
Why?
|
| Interferons | 1 | 2010 | 705 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2010 | 2262 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 7380 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4111 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 5419 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 3970 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6542 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 13456 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2015 | 3046 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2013 | 5427 | 0.010 |
Why?
|
| Leukocytes | 1 | 2010 | 2030 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6070 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 4353 | 0.010 |
Why?
|
| Risk Factors | 1 | 2023 | 74167 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 12774 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 18968 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9374 | 0.010 |
Why?
|
| DNA | 1 | 2008 | 7237 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 16532 | 0.010 |
Why?
|
| Female | 2 | 2023 | 390240 | 0.000 |
Why?
|
| Male | 1 | 2008 | 358719 | 0.000 |
Why?
|